143
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma

, , &
Pages 625-631 | Published online: 08 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lisa M Nijm, Justin Schweitzer & Jennifer Gould Blackmore. (2023) Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat. Clinical Ophthalmology 17, pages 3063-3076.
Read now
María de los Angeles Ramos-Cadena & George L. Spaeth. (2016) Ocular surface disease and glaucoma. Expert Review of Ophthalmology 11:3, pages 215-226.
Read now

Articles from other publishers (26)

Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil, Reiko Arita, Miriam Kolko, Jelle Vehof & Tor P. Utheim. (2022) Topical glaucoma medications – Clinical implications for the ocular surface. The Ocular Surface 26, pages 19-49.
Crossref
Moo Hyun Kim & Su-Ho Lim. (2022) Matrix Metalloproteinases and Glaucoma. Biomolecules 12:10, pages 1368.
Crossref
Sang-Woo Park, Jiwoong Lee & Michael Kook. (2022) Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease. Pharmaceuticals 15:2, pages 201.
Crossref
Yiming Ye, Yunzhi Xu, Yangfan Yang, Yanmei Fan, Pingping Liu, Keming Yu & Minbin Yu. (2022) Wide Corneal Epithelial Thickness Mapping in Eyes With Topical Antiglaucoma Therapy Using Optical Coherence Tomography. Translational Vision Science & Technology 11:1, pages 4.
Crossref
Jo-Hsuan WuTsing-Hong WangJehn-Yu HuangChien-Chia Su. (2021) Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost. Journal of Ocular Pharmacology and Therapeutics 37:10, pages 556-564.
Crossref
Chien-Chia Su, Yi-Chieh Lee & Peter Richmond Candano Lee. (2021) RETRACTED ARTICLE: Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study. Graefe's Archive for Clinical and Experimental Ophthalmology 259:5, pages 1243-1251.
Crossref
Elizabeta Marceta & Dusan Todorovic. (2021) The Effect of Glaucoma on the Quality of Patient’s Life. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Martina Janderová, Aleš Filouš, Martin Hložánek, Dagmar Dotřelová & Gabriela Mahelková. (2021) The Effect of Therapy on the Ocular Surface in Patients with Unilateral Paediatric Glaucoma. Czech and Slovak Ophthalmology 77:1, pages 28-34.
Crossref
Dai Woo Kim, Je Hyun Seo & Su-Ho Lim. (2020) Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears. Eye 35:3, pages 892-900.
Crossref
Adriano Guarnieri, Elena Carnero, Anne-Marie Bleau, Belén Alfonso-Bartolozzi & Javier Moreno-Montañés. (2019) Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients. International Ophthalmology 40:3, pages 741-751.
Crossref
Ammar El Ameen, Guillaume Vandermeer, Raoul K Khanna & Pierre-Jean Pisella. (2018) Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues. European Journal of Ophthalmology 29:6, pages 645-653.
Crossref
Anna Zaleska-Żmijewska, Ewa Strzemecka, Zbigniew M. Wawrzyniak & Jacek P. Szaflik. (2019) Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma. Journal of Ophthalmology 2019, pages 1-7.
Crossref
Daniel Tiedemann, Zaynab A. Mouhammad, Tor P. Utheim, Darlene A. Dartt, Steffen Heegaard, Goran Petrovski & Miriam Kolko. (2019) Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment. Journal of Glaucoma 28:4, pages 325-333.
Crossref
Xuemin Zhang, Saujanya Vadoothker, Wuqaas M. Munir & Osamah Saeedi. (2019) Ocular Surface Disease and Glaucoma Medications: A Clinical Approach. Eye & Contact Lens: Science & Clinical Practice 45:1, pages 11-18.
Crossref
Gilda Cennamo, Daniela Montorio, Salvatore Del Prete, Antonio Del Prete & Giovanni Cennamo. (2018) Anterior-Segment Optical Coherence Tomography and Scanning Electron Microscopy to Evaluate Corneal Epithelial Changes in Patients Undergoing Glaucoma Therapy. Cornea 37:12, pages 1522-1526.
Crossref
Ayisha Kausar, Mahmood Ali, Haleema Masud & Farah Akhtar. (2018) Vision-related quality of life in Pakistani subjects with early or moderate glaucoma. International Health 10:6, pages 517-523.
Crossref
Ngamkae RuangvaravatePinnita PrabhasawatVirunya VachirasakchaiRatchadaporn Tantimala. (2018) High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand. Journal of Ocular Pharmacology and Therapeutics 34:5, pages 387-394.
Crossref
C. Erb. (2017) Derzeitige Entwicklungen in der minimalinvasiven GlaukomchirurgieCurrent developments in minimally invasive glaucoma surgery. Der Ophthalmologe 115:5, pages 360-362.
Crossref
Tae Hee Lee, Mi Sun Sung, Hwan Heo & Sang Woo Park. (2018) Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma. PLOS ONE 13:1, pages e0191398.
Crossref
Kristin Schmid Biggerstaff & Albert Lin. (2018) Glaucoma and Quality of Life. International Ophthalmology Clinics 58:3, pages 11-22.
Crossref
Francisco Pérez-Bartolomé, Jose M. Martínez-de-la-Casa, Pedro Arriola-Villalobos, Cristina Fernández-Pérez, Vicente Polo & Julián García-Feijoó. (2017) Ocular Surface Disease in Patients under Topical Treatment for Glaucoma. European Journal of Ophthalmology 27:6, pages 694-704.
Crossref
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Nathan Efron, Masatoshi Hirayama, Jutta Horwath-Winter, Terry Kim, Jodhbir S. Mehta, Elisabeth M. Messmer, Jay S. Pepose, Virender S. Sangwan, Alan L. Weiner, Steven E. Wilson & James S. Wolffsohn. (2017) TFOS DEWS II iatrogenic report. The Ocular Surface 15:3, pages 511-538.
Crossref
Anastasios-Georgios Konstas, Konstadinos G. Boboridis, Paraskevas Kapis, Konstantinos Marinopoulos, Irini C. Voudouragkaki, Dimitrios Panayiotou, Dimitrios G. Mikropoulos, Eirini Pagkalidou, Anna-Bettina Haidich, Andreas Katsanos & Luciano Quaranta. (2016) 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy. Advances in Therapy 34:1, pages 221-235.
Crossref
J. M. Sanchez, V. Cacace, C. F. Kusnier, R. Nelson, A. A. Rubashkin, P. Iserovich & J. Fischbarg. (2016) Net Fluorescein Flux Across Corneal Endothelium Strongly Suggests Fluid Transport is due to Electro-osmosis. The Journal of Membrane Biology 249:4, pages 469-473.
Crossref
Sung A. Lim & So-Hyang Chung. (2016) Reply. Cornea 35:4, pages e11.
Crossref
V. Cacace, C. F. Kusnier & J. Fischbarg. (2015) RETRACTED ARTICLE: Net Fluorescein Flux Across Corneal Endothelium Suggests Fluid Transport is Driven by Electroosmosis. The Journal of Membrane Biology 249:1-2, pages 197-197.
Crossref